The global sales of non-steroid anti-inflammatory and antirheumatic medicines vary significantly across countries. As of 2023, Germany leads with $689.5 million in sales, followed by Croatia and Italy, with $398.8 million and $249.3 million, respectively. Most countries saw modest to significant changes: Croatia and Latvia reported growth rates of 2.89% and 3.03%, while Hungary and Denmark saw declines of 6.54% and 4.53%. Germany, the largest market, experienced a slight decrease of 0.93%. The compound annual growth rates over the past five years show moderate trends, with certain markets positioned for continued expansion.
Key future trends to watch include:
- The impact of an aging population on demand in Europe.
- Emerging markets in Eastern Europe potentially increasing their market share.
- Technological advancements and new drug formulations that may influence consumption patterns.
- Regulatory changes in international markets that could affect market dynamics differently across regions.
Top countries in Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 689.5 | 2023 | +1.14% | -0.93% | View data |
| 2 | 2 Croatia | 398.8 | 2023 | +3.56% | +2.89% | View data |
| 3 | 3 Italy | 249.3 | 2023 | -1.23% | +2.17% | View data |
| 4 | 4 Belgium | 131.9 | 2023 | -0.076% | +1.05% | View data |
| 5 | 5 Sweden | 81.4 | 2023 | -2.4% | -0.67% | View data |
| 6 | 6 Finland | 57.4 | 2023 | +0.17% | +1.49% | View data |
| 7 | 7 Austria | 46.9 | 2023 | -0.42% | -0.95% | View data |
| 8 | 8 Latvia | 37.5 | 2023 | -2.6% | +3.03% | View data |
| 9 | 9 Hungary | 28.6 | 2023 | -6.84% | -6.54% | View data |
| 10 | 10 Denmark | 27.6 | 2023 | -2.47% | -4.53% | View data |
